However, interventions which prevent and/or attenuate Cx43 disorders can provide benefits [14,19], and it is important here that the unique properties of omega-3 polyunsaturated fatty acids, such as Omacor® are permanent subjects of investigation in the protection of cardiovascular health and prevention of cardiac arrhythmias [20]. The gene discussed is GJA1; the disease is cardiac arrhythmia.